| Product Code: ETC9964622 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Drug-eluting Stents Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Drug-eluting Stents Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Drug-eluting Stents Market - Industry Life Cycle |
3.4 United States (US) Drug-eluting Stents Market - Porter's Five Forces |
3.5 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.7 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By Generation, 2021 & 2031F |
3.8 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By Scaffold, 2021 & 2031F |
3.9 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 United States (US) Drug-eluting Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Drug-eluting Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the United States |
4.2.2 Technological advancements leading to the development of innovative drug-eluting stents |
4.2.3 Growing adoption of minimally invasive procedures in cardiology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High cost associated with drug-eluting stents leading to limited affordability for some patients |
5 United States (US) Drug-eluting Stents Market Trends |
6 United States (US) Drug-eluting Stents Market, By Types |
6.1 United States (US) Drug-eluting Stents Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By Polymer-based, 2021- 2031F |
6.1.4 United States (US) Drug-eluting Stents Market Revenues & Volume, By Polymer-free, 2021- 2031F |
6.2 United States (US) Drug-eluting Stents Market, By Drug |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By Sirolimus, 2021- 2031F |
6.2.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By Paclitaxel, 2021- 2031F |
6.2.4 United States (US) Drug-eluting Stents Market Revenues & Volume, By Zotarolimus, 2021- 2031F |
6.2.5 United States (US) Drug-eluting Stents Market Revenues & Volume, By Everolimus, 2021- 2031F |
6.2.6 United States (US) Drug-eluting Stents Market Revenues & Volume, By Biolimus, 2021- 2031F |
6.2.7 United States (US) Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Drug-eluting Stents Market, By Generation |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By 1st Generation, 2021- 2031F |
6.3.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By 2nd Generation, 2021- 2031F |
6.3.4 United States (US) Drug-eluting Stents Market Revenues & Volume, By 3rd Generation, 2021- 2031F |
6.3.5 United States (US) Drug-eluting Stents Market Revenues & Volume, By 4th Generation, 2021- 2031F |
6.4 United States (US) Drug-eluting Stents Market, By Scaffold |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By Cobalt-Chromium, 2021- 2031F |
6.4.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By Platinum-Chromium, 2021- 2031F |
6.4.4 United States (US) Drug-eluting Stents Market Revenues & Volume, By Nitinol, 2021- 2031F |
6.4.5 United States (US) Drug-eluting Stents Market Revenues & Volume, By Biodegradable, 2021- 2031F |
6.4.6 United States (US) Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Drug-eluting Stents Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By Coronary Diseases, 2021- 2031F |
6.5.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By Peripheral Vascular Diseases, 2021- 2031F |
6.6 United States (US) Drug-eluting Stents Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Drug-eluting Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Drug-eluting Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
7 United States (US) Drug-eluting Stents Market Import-Export Trade Statistics |
7.1 United States (US) Drug-eluting Stents Market Export to Major Countries |
7.2 United States (US) Drug-eluting Stents Market Imports from Major Countries |
8 United States (US) Drug-eluting Stents Market Key Performance Indicators |
8.1 Average selling price of drug-eluting stents |
8.2 Number of clinical trials and studies conducted on drug-eluting stents in the US |
8.3 Adoption rate of drug-eluting stents compared to bare-metal stents in cardiac procedures |
9 United States (US) Drug-eluting Stents Market - Opportunity Assessment |
9.1 United States (US) Drug-eluting Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Drug-eluting Stents Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.3 United States (US) Drug-eluting Stents Market Opportunity Assessment, By Generation, 2021 & 2031F |
9.4 United States (US) Drug-eluting Stents Market Opportunity Assessment, By Scaffold, 2021 & 2031F |
9.5 United States (US) Drug-eluting Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 United States (US) Drug-eluting Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Drug-eluting Stents Market - Competitive Landscape |
10.1 United States (US) Drug-eluting Stents Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Drug-eluting Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here